Spots Global Cancer Trial Database for A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib
Official Title: A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effect of a Breast Cancer Resistance Protein Inhibitor on the Single-dose Pharmacokinetics of Adagrasib in Healthy Adult Subjects
Study ID: NCT05924152
Conditions
Study Description
Brief Summary: A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effect of a Breast Cancer Resistance Protein Inhibitor on the Single-dose Pharmacokinetics of Adagrasib in Healthy Adult Subjects
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical Research Unit Daytona Beach), Daytona Beach, Florida, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
